Which vaccines are indicated for a healthy 17‑year‑old, including Tdap (tetanus, diphtheria, pertussis), HPV (human papillomavirus), MenACWY (meningococcal conjugate), MenB (meningococcal B), influenza, COVID‑19 booster, MMR (measles‑mumps‑rubella), varicella, hepatitis B, and hepatitis A as needed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vaccines Recommended for a 17-Year-Old

A healthy 17-year-old should receive Tdap (if not previously given), MenACWY booster (if first dose was before age 16), HPV vaccine series (if not completed), annual influenza vaccine, and COVID-19 primary series plus booster if not up to date. 1

Core Adolescent Vaccines

Tdap (Tetanus, Diphtheria, Pertussis)

  • One dose of Tdap is required if not previously received at age 11-12 years 1, 2
  • This replaces the older Td booster and provides critical pertussis protection during adolescence 1, 3
  • Coverage with Tdap reached 90.1% nationally by 2020, indicating this is a well-established standard 2

MenACWY (Meningococcal Conjugate)

  • A booster dose at age 16 years is recommended if the first dose was given before age 16 1, 2
  • If the first dose was given at or after age 16, no booster is needed 1
  • For a 17-year-old, verify timing of the first dose to determine if a booster is due 1
  • This booster addresses waning immunity, as disease incidence increases in late adolescence 1

HPV (Human Papillomavirus)

  • The HPV vaccine series should be completed if not already done 1, 2
  • For adolescents who start the series at age 15 or older, a 3-dose schedule is required (0,1-2, and 6 months) 1
  • HPV vaccination coverage remains suboptimal at 58.6% for series completion as of 2020, representing a critical gap 2
  • This vaccine prevents multiple cancers and is recommended for both males and females 1, 3

Influenza Vaccine

  • Annual influenza vaccination is recommended for all adolescents 1, 2
  • This should be administered every fall/winter season 3
  • Coverage was only 46.8% in the 2015-2016 season among 13-17 year olds, indicating significant room for improvement 1

COVID-19 Vaccine

  • Primary series and booster doses should be administered according to current ACIP recommendations 1
  • Specific dosing depends on which vaccine product is used and the adolescent's immunocompromise status 1

Catch-Up Vaccines (If Childhood Series Incomplete)

MMR (Measles, Mumps, Rubella)

  • Two doses are required; verify completion and administer any missing doses 1, 4, 2
  • The Healthy People 2010 objective of 90% coverage was met for MMR, but individual verification remains essential 4

Varicella (Chickenpox)

  • Two doses are required for those without disease history; complete the series if needed 1, 4, 2
  • The 90% coverage objective was met nationally, but individual assessment is necessary 4

Hepatitis B

  • Three-dose series should be completed if not done in childhood 1, 4, 2
  • This met the 90% coverage target nationally but requires individual verification 4

Hepatitis A

  • Two-dose series should be completed if not previously given 1, 2
  • Coverage increased in 2020, reflecting growing recognition of this vaccine's importance 2

Special Consideration: MenB (Meningococcal B)

  • Shared clinical decision-making is recommended for MenB vaccination in adolescents aged 16-23 years 2
  • This is not a routine recommendation but should be discussed, particularly for adolescents at increased risk (college students, those living in dormitories) 1, 2
  • If given, a 2-dose series is required with specific intervals depending on the product 1

Critical Implementation Points

Simultaneous Administration

  • All indicated vaccines can and should be given during the same visit 1, 5, 6
  • This increases completion rates and provides timely protection 5, 6
  • Each vaccine should be administered at separate anatomic sites using different syringes 5, 6

Common Pitfalls to Avoid

  • Do not delay HPV vaccination - this remains the most under-utilized adolescent vaccine despite strong evidence for cancer prevention 1, 2
  • Do not forget the MenACWY booster at age 16 - waning immunity makes this dose critical 1
  • Do not assume childhood vaccines are complete - verify MMR, varicella, and hepatitis B status 4, 2
  • Do not miss the annual influenza vaccine - this requires administration every year, not just once 1, 2

Documentation

  • Verify immunization records from all previous providers 1
  • Document all vaccines administered in the permanent medical record 5, 6
  • Provide the adolescent/parent with an updated immunization record 5, 6

Contraindications

  • Defer vaccination if moderate to severe acute illness is present 5, 6
  • Live vaccines (MMR, varicella) are contraindicated in immunocompromised individuals 7, 6
  • Severe allergic reactions to vaccine components are contraindications 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Update on Routine Childhood and Adolescent Immunizations.

American family physician, 2015

Guideline

Simultaneous Administration of DTaP, Hepatitis B, MMR, and Varicella Vaccines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vaccine Administration Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vaccination Recommendations for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.